In vitro Activity of Azithromycin in Combination with Amikacin, Ceftazidime, Ciprofloxacin or Imipenem against Clinical Isolates of Acinetobacter baumannii

Publisher： Karger

E-ISSN： 1421-9794|49|1-2|24-26

ISSN： 0009-3157

Source： Chemotherapy, Vol.49, Iss.1-2, 2003-05, pp. : 24-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Activity of Levofloxacin and Ciprofloxacin in Combination with Cefepime, Ceftazidime, Imipenem, Piperacillin-Tazobactam and Amikacin against Different Pseudomonas aeruginosa Phenotypes and Acinetobacter spp.

By  

Chemotherapy, Vol. 50, Iss. 4, 2004-10 ,pp. : 202-210

Karger

Access to resources Recommend Favorite

Effect of Ceftazidime, Amikacin and Ciprofloxacin on Biofilm Formation by Some Enterobacterial Clinical Isolates

By  

Chemotherapy, Vol. 50, Iss. 5, 2004-11 ,pp. : 255-259

Karger

Access to resources Recommend Favorite

In vitro Activity of Ceftazidime, Cefepime and Imipenem on 1,005 Pseudomonas aeruginosa Clinical Isolates either Susceptible or Resistant to Beta-Lactams

By  

Chemotherapy, Vol. 46, Iss. 4, 2000-06 ,pp. : 229-234

Karger

Access to resources Recommend Favorite

Once versus Thrice Daily Tobramycin Alone and in Combination with Ceftazidime, Ciprofloxacin and Imipenem in an in vitro Pharmacodynamic Model

By  

Chemotherapy, Vol. 44, Iss. 1, 1997-12 ,pp. : 1-6

Karger

Access to resources Recommend Favorite

Study of the Correlation of Imipenem Resistance with Efflux Pumps AdeABC, AdeIJK, AdeDE and AbeM in Clinical Isolates of Acinetobacter baumannii

By  

Chemotherapy, Vol. 58, Iss. 2, 2012-05 ,pp. : 152-158

Karger

Access to resources Recommend Favorite